Dr. Cassandra Key

Geriatrics
Ipc Healthcare Services Of Texas PLLC
7330 San Pedro Ave Ste 540, 
San Antonio, TX 
Ipc Healthcare Services Of Texas PLLC
7330 San Pedro Ave Ste 540, 
San Antonio, TX 

Overview

Cassandra Key is a primary care provider, practicing in Geriatrics in San Antonio, Texas.

Her clinical expertise encompasses Autosomal Dominant Polycystic Kidney Disease and Polycystic Kidney Disease.

She is actively involved in clinical research, co-authoring 5 peer reviewed articles and participating in 7 clinical trials.

Specialties

Geriatrics

Licenses

Internal Medicine in TX

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO

Locations

Ipc Healthcare Services of Texas PLLC
7330 San Pedro Ave Ste 540, San Antonio, TX 78216

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase 1, Double-Blind, Placebo-Controlled, Single Ascending Dose Study in Healthy Volunteers to Evaluate the Safety, Tolerability, and Pharmacokinetics of RGLS8429
A Phase 1, Double-Blind, Placebo-Controlled, Single Ascending Dose Study in Healthy Volunteers to Evaluate the Safety, Tolerability, and Pharmacokinetics of RGLS8429
Enrollment Status: Completed
Publish Date: August 27, 2025
Intervention Type: Drug
Study Phase: Phase 1
A Phase 1, Randomized, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety, Tolerability, and PK of LY3541105 Following Single Doses in Healthy/Overweight Participants and Multiple Doses in Overweight Participants
A Phase 1, Randomized, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety, Tolerability, and PK of LY3541105 Following Single Doses in Healthy/Overweight Participants and Multiple Doses in Overweight Participants
Enrollment Status: Completed
Publish Date: June 27, 2025
Intervention Type: Drug
Study Phase: Phase 1
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study to Evaluate the Safety, Pharmacokinetics, and Immunogenicity of ADM03820 in Adults
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study to Evaluate the Safety, Pharmacokinetics, and Immunogenicity of ADM03820 in Adults
Enrollment Status: Completed
Publish Date: March 07, 2025
Intervention Type: Other, Drug
Study Drug: ADM03820 Anti-COVID-19 Vaccine
Study Phase: Phase 1
CSD190202: A Randomized, Open-Label, Crossover Study to Assess Elements of Abuse Liability for Two Electronic Nicotine Delivery Systems
CSD190202: A Randomized, Open-Label, Crossover Study to Assess Elements of Abuse Liability for Two Electronic Nicotine Delivery Systems
Enrollment Status: Completed
Publish Date: June 27, 2022
Intervention Type: Other
Study Phase: Not Applicable
A Phase 1b, Multicenter, Open-Label, Adaptive Design Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RGLS4326 Administered Via SC Injection to Patients With Autosomal Dominant Polycystic Kidney Disease
A Phase 1b, Multicenter, Open-Label, Adaptive Design Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RGLS4326 Administered Via SC Injection to Patients With Autosomal Dominant Polycystic Kidney Disease
Enrollment Status: Completed
Publish Date: December 15, 2021
Intervention Type: Drug
Study Drug: RGLS4326
Study Phase: Phase 1
A Multi-Center, Randomized, Placebo-Controlled, Phase 1, Two-Part Study Designed to Assess the Safety, Tolerability, Pharmacokinetics, Food Effect, and Drug-Drug Interactions of PTI-801 in Healthy Volunteers, and Safety, Tolerability, and Pharmacokinetics of PTI-801 in Subjects With Cystic Fibrosis
A Multi-Center, Randomized, Placebo-Controlled, Phase 1, Two-Part Study Designed to Assess the Safety, Tolerability, Pharmacokinetics, Food Effect, and Drug-Drug Interactions of PTI-801 in Healthy Volunteers, and Safety, Tolerability, and Pharmacokinetics of PTI-801 in Subjects With Cystic Fibrosis
Enrollment Status: Completed
Publish Date: April 30, 2020
Intervention Type: Drug
Study Phase: Phase 1
Comparative Pharmacokinetics and Food-Effect Bioavailability of a Sprinkle Formulation of Lubiprostone After Oral Administration in Healthy Volunteers
Comparative Pharmacokinetics and Food-Effect Bioavailability of a Sprinkle Formulation of Lubiprostone After Oral Administration in Healthy Volunteers
Enrollment Status: Completed
Publish Date: March 09, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 6 Less Clinical Trials

5 Total Publications

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Long-Acting FGF21 Analog Zalfermin.
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Long-Acting FGF21 Analog Zalfermin.
Journal: Clinical and translational science
Published: July 07, 2025
Similar Doctors
Expertise in
19
conditions
Dr. Andres Pardo
Geriatrics
Expertise in
19
conditions
Dr. Andres Pardo
Geriatrics

Lutheran General Hosp HH Care Dept

701 S Zarzamora St, 
San Antonio, TX 
 (6.8 miles away)
210-358-7552
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Andres Pardo is a primary care provider, practicing in Geriatrics in San Antonio, Texas. Dr. Pardo is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Diabetic Neuropathy, Hypertension, and Glucocorticoid-Remediable Aldosteronism.

Expertise in
24
conditions
Dr. Jibrail Kasperkhan
Geriatrics
Expertise in
24
conditions
Dr. Jibrail Kasperkhan
Geriatrics

Five Star Quality Care-TX LLC

511 Knights Cross Dr, 
San Antonio, TX 
 (8.1 miles away)
210-404-2687
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jibrail Kasperkhan is a primary care provider, practicing in Geriatrics in San Antonio, Texas. Dr. Kasperkhan is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Dementia, Alzheimer's Disease, Muscle Atrophy, and Familial Hypertension.

Expertise in
20
conditions
Dr. Rosa Vizcarra
Geriatrics
Expertise in
20
conditions
Dr. Rosa Vizcarra
Geriatrics

Office

9969 Fredericksburg Rd, 
San Antonio, TX 
 (5.0 miles away)
210-690-2273
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Rosa Vizcarra is a primary care provider, practicing in Geriatrics in San Antonio, Texas. Dr. Vizcarra is highly rated in 20 conditions, according to our data. Her clinical expertise encompasses Cirrhosis, Familial Combined Hyperlipidemia, Xanthoma, and High Cholesterol.

Frequently Asked Questions about Dr. Cassandra Key

How do I make an appointment with Dr. Cassandra Key?

You can book an appointment with Dr. Cassandra Key by calling their office at 210-344-7287. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Cassandra Key a top-rated expert for Autosomal Dominant Polycystic Kidney Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Cassandra Key is classified as an Experienced expert for Autosomal Dominant Polycystic Kidney Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Cassandra Key specialize in?

While Dr. Cassandra Key is a Geriatrics, they have specific expertise in Autosomal Dominant Polycystic Kidney Disease, Polycystic Kidney Disease. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Geriatrics.

Does Dr. Cassandra Key participate in research or clinical trials?

Yes. Dr. Cassandra Key has published 5 articles and abstracts on conditions like Autosomal Dominant Polycystic Kidney Disease. You can view a list of Dr. Cassandra Key's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Cassandra Key accept my insurance?

Dr. Cassandra Key accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 210-344-7287 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Key's expertise for a condition
ConditionClose
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile